Form 483

Corporacion Avicola Morovis, Inc. Form 483, 2014-11-28

FDA issued a Form 483 to Corporacion Avicola Morovis, Inc. on 2014-11-28 with 8 public-safe observations.

483· Form 483 issuedFoods & Cosmetics8 observations

Corporacion Avicola Morovis, Inc. · Morovis, United States · Issued November 28, 2014

Overview

  • 8 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Nov 2014
21 CFR 110.20(b)(2)

Contamination with microorganisms, chemicals, filth, etc.

Cited by Pablo Feliciano, Karl D Hezel

28 Nov 2014
21 CFR 118.4

Written SE plan lacks required elements

Cited by Pablo Feliciano, Karl D Hezel

28 Nov 2014
21 CFR 118.4

Written SE plan not implemented/followed

Cited by Pablo Feliciano, Karl D Hezel

28 Nov 2014
21 CFR 118.4(b)(4)

Stray animals

Cited by Pablo Feliciano, Karl D Hezel

28 Nov 2014
21 CFR 118.4(d) (1)

Visible manure

Cited by Pablo Feliciano, Karl D Hezel

Inspected site

CACorporacion Avicola Morovis, Inc.Morovis, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 118.4Cited across public-safe Form 483 observations2x
21 CFR 110.20(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 118.10(a)(3)(i)Cited across public-safe Form 483 observations1x
21 CFR 118.10(a)(3)(iii)Cited across public-safe Form 483 observations1x
21 CFR 118.4(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 118.4(d) (1)Cited across public-safe Form 483 observations1x
21 CFR 118.7(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 8 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere